TeamTalk: Meet the MiRXES Wonder Women
Across the many functional teams in MiRXES, from R&D to manufacturing and commercial, our women in science wear many different hats—to great success.
TeamTalk: Meet the MiRXES Wonder Women Read More »
Insights
The genesis of GASTROClear
As the world’s first molecular blood test for detecting gastric cancer, GASTROClear could play a pivotal role in stopping the deadly disease in its earliest stages.
The genesis of GASTROClear Read More »
Leveling up with MiRXES
Insights Leveling up with MiRXES MiRXES is on the lookout for talents who can contribute to its mission against diseases like cancer through leading-edge diagnostic tools. MiRXES team in action As the saying goes, the early bird catches the worm—and nowhere is this truer than in the world of healthcare. Each year, over a million
Leveling up with MiRXES Read More »
MiRXES TeamTalk: Jeremiah Decosta
Insights TeamTalk: Jeremiah Decosta As Vice President for Manufacturing and Regulatory Affairs at MiRXES, Jeremiah Decosta harnesses smart technologies to accelerate processes in the plants while ensuring quality diagnostics. Jeremiah Decosta, VP for Manufacturing & Regulatory Affairs at MiRXES. In the world of medical diagnostics manufacturing, there’s no room for error. Even the smallest slip-up
MiRXES TeamTalk: Jeremiah Decosta Read More »
Meeting the microRNA Profiling Challenge
Insights Meeting the microRNA Profiling Challenge Compared to other commercial microRNA profiling platforms, MiRXES’s ID3EAL qPCR platform stands out when used to discover and validate blood-based miRNA biomarkers. From painful biopsies to invasive procedures, certain diagnostic exams have gotten a bad rap over the years for the discomfort they tend to cause. The 2008 discovery
Meeting the microRNA Profiling Challenge Read More »
MiRXES TeamTalk: Dr Cheng He
Insights TeamTalk: Dr Cheng He For Dr. Cheng He, Vice President for Research and Development at MiRXES, research is all about innovating for impact and improving people’s health in the process. Dr Cheng He, VP for R&D at MiRXES. In MiRXES’ earliest days, the company made its mark with its reverse transcription-quantitative polymerase chain reaction
MiRXES TeamTalk: Dr Cheng He Read More »
MiRXES TeamTalk: Dr Zhou Lihan
Insights TeamTalk: Dr Zhou Lihan As Co-founder and CEO of MiRXES, Dr Zhou Lihan has led the company in its journey from humble start-up to a global leader in miRNA-powered diagnostics. Dr Zhou Lihan, Co-founder and Chief Executive Officer of MiRXES. It’s been over a decade since MiRXES was first dreamed up in the laboratories
MiRXES TeamTalk: Dr Zhou Lihan Read More »
Pandemic Pivot Pays Off
Insights MiRXES’ Pandemic Pivot Pays Off Armed with a wealth of experience from the pandemic, MiRXES is now set to return to its roots and focus on producing best-in-class multi-cancer early diagnostics. 2020 was anything but business as usual, but human ingenuity shone amid the uncertainty. Even as the coronavirus spread swiftly across the globe,
Pandemic Pivot Pays Off Read More »
Fortitude at the Forefront
Insights Fortitude at the Forefront Amidst the highs and lows of 2020, MiRXES managed to rise to the occasion and make our name on a global stage. For many of us at MiRXES, 2020 can be summed up in a single word: Fortitude. Not only is Fortitude the name of the COVID-19 test kit we
Fortitude at the Forefront Read More »
Working hand in hand for heart health and beyond
Insights Working hand in hand for heart health and beyond Discover how MiRXES and its partners are developing early detection tests to fight the world’s leading cause of death: heart disease. MiRXES is teaming up with partners and collaborators from the industry, academia and clinics around the world to unlock the potential of miRNA
Working hand in hand for heart health and beyond Read More »